SMS Pharmaceuticals share news, announcements and annual reports
NSE: SMSPHARMABSE: 532815Pharmaceuticals & BiotechnologySmall Cap
SMS Pharmaceuticals Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2007
Last close ₹475.45up ₹32.65 (7.37%)BSE ₹477.00
Share price at the NSE close on 28 Oct 2026. Previous close ₹442.80.
28 Oct: open ₹435.00, high ₹478.00, low ₹435.00
52-week range of traded prices to 28 Oct 2026
₹270.10Low, 24 Nov 2025₹494.45High, 22 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,453 Cr920th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 43.36
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.67
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.08%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 14.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.46
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,77,21443.9% delivered
SMS Pharmaceuticals disputes and clarifications
17 filed, newest first.
Jul 2026
1 Jul · Legal
The exchange asked on 30 Jun 2026
Apr 2026
29 Apr · Legal
Mar 2026
31 Mar · Legal
Sep 2025
12 Sep · Legal
Mar 2025
24 Mar · Legal
Aug 2024
24 Aug · Legal
The exchange asked on 23 Aug 2024
Apr 2023
26 Apr · Legal
The exchange asked on 25 Apr 2023
Feb 2022
11 Feb · Legal
Exchange has sought clarification from SMS Pharmaceuticals Limited with respect to announcement dated 09-Feb-2022, regarding Board meeting held on February 09, 2022. On basis of above the Company is required to clarify following: 1. Date of appointment/cessation (as applicable) & term of appointment2. Brief profile (in case of appointment)The response of the Company is awaited.
May 2020
4 May · Legal
The exchange asked on 30 Apr 2020
Apr 2020
13 Apr · Legal
The exchange asked on 9 Apr 2020
Jun 2018
May 2018
29 May · Legal
Exchange has sought clarification from SMS Pharmaceuticals Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Standalone Reconciliation of Equity not submitted The response of the Company is awaited.29 May · Legal
Exchange has sought clarification from SMS Pharmaceuticals Limited with respect to announcement dated 26-May-2018, regarding " SMS Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 26, 2018 has recommended a dividend of Rs. 0.25(25%) per equity share of Rs. 1/-(Rupee One) each, for the financial year ended March 31, 2018.". On basis of above the Company is required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director).2. Brief profile (in case of appointment);The response of the Company is awaited.
Jun 2017
May 2017
31 May · Legal
Exchange has sought clarification from SMS Pharmaceuticals Limited with respect to announcement dated 30-May-2017, regarding " Appointment of Statutory Auditor of the company ". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment);The response of the Company is awaited.